Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mañá, P.
Right arrow Articles by Liñares, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mañá, P.
Right arrow Articles by Liñares, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 3, pp. 489-499, March 2004
© 2004 Japanese Society for Immunology

Tolerance induction by molecular mimicry: prevention and suppression of experimental autoimmune encephalomyelitis with the milk protein butyrophilin

Paula Mañá1,4, Melinda Goodyear1,2, Claude Bernard3, Ryo Tomioka5, Manuel Freire-Garabal4 and David Liñares1,4

1 Department of Biochemistry, 2 School of Psychological Science and 3 Neuroimmunology Laboratory; La Trobe University, Bundoora, Victoria 3086, Australia 4 Department of Pharmacology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela 15705, Spain 5 Department of Neurology, Saitama Medical School, Saitama 350-0495, Japan

P. Mañá and D. Liñares
Correspondence to: P. Mañá, Department of Pharmacology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela 15705, Spain. E-mail: vaques{at}usc.es
Transmitting editor: C. Martinez-A

Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system. Although the etiology of MS remains unknown, studies in experimental autoimmune encephalomyelitis (EAE) have suggested that foreign molecules, which show molecular mimicry with myelin antigens, may play an important role as causative agents of the human disease. In this study, we investigate the molecular mimicry between the extracellular Ig-like domain of the cow’s milk protein butyrophilin (BTN) and the extracellular domain of myelin oligodendrocyte glycoprotein (MOG), a candidate autoantigen in MS. Interestingly, we found that as a result of a non-pathogenic cross-reactivity that is localized to a subdominant region of MOG, treatment of C57BL/6 mice with BTN either before or after immunization with MOG was shown to prevent and also suppress the clinical manifestations of EAE. BTN treatment resulted in a significant reduction in both proliferation and production of Th1-related cytokines (IFN-{gamma}, IL-2, IL-12 and granulocyte macrophage colony stimulating factor) in response to MOG. This specific inhibition was consistently associated with an up-regulation in IL-10 secretion. Furthermore, adoptive transfer of BTN-specific T cells prior to active immunization with MOG resulted in a transitory reduction of the clinical symptoms. Our results suggest that the clinical improvement associated with BTN treatment involved the combination of both anergy and regulatory cells secreting high levels of IL-10. In conclusion, we show that despite the traditional link between molecular mimicry and pathogenic immune response, environmental agents that share homology with autoantigens may also represent a source of cells with a protective phenotype.

Keywords: anergy, IL-10, milk, molecular mimicry, myelin oligodendrocyte glycoprotein


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Jeong, A. U. Rao, J. Xu, S. L. Ogg, Y. Hathout, C. Fenselau, and I. H. Mather
The PRY/SPRY/B30.2 Domain of Butyrophilin 1A1 (BTN1A1) Binds to Xanthine Oxidoreductase: IMPLICATIONS FOR THE FUNCTION OF BTN1A1 IN THE MAMMARY GLAND AND OTHER TISSUES
J. Biol. Chem., August 14, 2009; 284(33): 22444 - 22456.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Otaegui, S. Mostafavi, C. C. A. Bernard, A. L. de Munain, P. Mousavi, J. R. Oksenberg, and S. E. Baranzini
Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
J. Immunol., September 15, 2007; 179(6): 4074 - 4082.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Gold, C. Linington, and H. Lassmann
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Brain, August 1, 2006; 129(8): 1953 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R P Lisak, J A Benjamins, B Bealmear, B Yao, S Land, L Nedelkoska, and D Skundric
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures
Multiple Sclerosis, April 1, 2006; 12(2): 149 - 168.
[Abstract] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, D. Calida, Z. Zhao, B. Gran, M. Kamoun, and A. Rostami
Loss of the Surface Antigen 3G11 Characterizes a Distinct Population of Anergic/Regulatory T Cells in Experimental Autoimmune Encephalomyelitis
J. Immunol., March 15, 2006; 176(6): 3366 - 3373.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
V. L. Spitsberg
Invited Review: Bovine Milk Fat Globule Membrane as a Potential Nutraceutical
J Dairy Sci, July 1, 2005; 88(7): 2289 - 2294.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.